ZNF525 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.354230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.853560E-01
Normal-vs-Stage2
1.648380E-01
Normal-vs-Stage3
1.317620E-01
Normal-vs-Stage4
9.978800E-01
Stage1-vs-Stage2
4.900000E-01
Stage1-vs-Stage3
5.110000E-01
Stage1-vs-Stage4
1.400760E-01
Stage2-vs-Stage3
2.150600E-01
Stage2-vs-Stage4
1.112790E-01
Stage3-vs-Stage4
9.353700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.602840E-01
Normal-vs-AfricanAmerican
3.182000E-01
Normal-vs-Asian
1.714610E-01
Caucasian-vs-AfricanAmerican
4.210800E-01
Caucasian-vs-Asian
4.238400E-01
AfricanAmerican-vs-Asian
8.635200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.886780E-01
Normal-vs-Female
9.840400E-02
Male-vs-Female
6.215000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.344000E-01
Normal-vs-Age(41-60Yrs)
2.521400E-01
Normal-vs-Age(61-80Yrs)
1.258600E-01
Normal-vs-Age(81-100Yrs)
7.591600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.276800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.413800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.151200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.066200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.322560E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.794400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.075450E-01
Normal-vs-Daily Drinker
1.750250E-01
Normal-vs-Weekly Drinker
7.012200E-02
Normal-vs-Occasional Drinker
4.348200E-01
Normal-vs-Social Drinker
1.841410E-01
Non Drinker-vs-Daily Drinker
3.359200E-01
Non Drinker-vs-Weekly Drinker
9.214200E-01
Non Drinker-vs-Occasional Drinker
8.828500E-02
Non Drinker-vs-Social Drinker
6.443000E-01
Daily Drinker-vs-Weekly Drinker
4.014800E-01
Daily Drinker-vs-Occasional Drinker
3.691600E-01
Daily Drinker-vs-Social Drinker
7.088400E-01
Weekly Drinker-vs-Occasional Drinker
1.226240E-01
Weekly Drinker-vs-Social Drinker
7.094600E-01
Occasional Drinker-vs-Social Drinker
2.775000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.005600E-01
Normal-vs-Grade 2
1.839590E-01
Normal-vs-Grade 3
2.098800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.997400E-01
Grade 1-vs-Grade 3
9.094000E-02
Grade 1-vs-Grade 4
3.005600E-01
Grade 2-vs-Grade 3
2.365800E-01
Grade 2-vs-Grade 4
1.839590E-01
Grade 3-vs-Grade 4
2.098800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.447600E-02
Normal-vs-NonDiabetic
2.133000E-01
Diabetic-vs-NonDiabetic
6.240100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.300100E-02
Normal-vs-NoPancreatitis
1.600160E-01
Pancreatitis-vs-NoPancreatitis
2.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.394440E-01
Normal-vs-N1
1.439020E-01
N0-vs-N1
8.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.775400E-01
Normal-vs-TP53-NonMutant
4.003400E-01
TP53-Mutant-vs-TP53-NonMutant
4.2382000000063E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
